Virbac

Muscling Up Dogs: Westlake-Based Virbac NA Launches Soft Chews That Improve Canine Mobility

by | Jan 9, 2025
Virbac said that URSOLYX Soft Chews target mRNA expression in skeletal muscle, harnessing the proven benefits of ursolic acid to enhance muscle function and strength in aging, active, or recovering dogs.
MORE
Westlake’s Virbac Announces Availability of New Dog Cancer Treatment Across the U.S.
by | Aug 16, 2021
Stelfonta received FDA approval last November to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs)—the most common malignant skin tumor in dogs. The injection is now available at vet clinics across the U.S., with an 88% "satisfactory experience" rate to date.
MORE